Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3481)
GALECTIN THERAPEUTICS INC (GALT)
LEWIS JOEL — Director
Shares
27,731
Price
$3.91
Total Value
$108.34K
Shares Held After
870,290
% of Holdings
3.1%
PTC THERAPEUTICS, INC. (PTCT)
Reeve Emma — Director
Shares
734
Price
$76.00
Total Value
$55.78K
Shares Held After
10,666
% of Holdings
6.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
108
Price
$76.79
Total Value
$8.29K
Shares Held After
120,901
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,035
Price
$76.10
Total Value
$78.76K
Shares Held After
121,009
% of Holdings
0.8%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
1,123
Price
$74.92
Total Value
$84.14K
Shares Held After
122,044
% of Holdings
0.9%
Solid Biosciences Inc. (SLDB)
Ganot Ilan — Director
Shares
1,053
Price
$5.43
Total Value
$5.72K
Shares Held After
17,278
% of Holdings
5.7%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
53,470
Price
$35.53
Total Value
$1.90M
Shares Held After
61,804
% of Holdings
46.4%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
139,245
Price
$34.83
Total Value
$4.85M
Shares Held After
115,274
% of Holdings
54.7%
Bicycle Therapeutics plc (BCYC)
Lee Kevin — Director
Shares
10,989
Price
$6.46
Total Value
$70.99K
Shares Held After
618,996
% of Holdings
1.7%
Bicycle Therapeutics plc (BCYC)
Young Alethia — Chief Financial Officer
Shares
1,878
Price
$6.54
Total Value
$12.28K
Shares Held After
87,081
% of Holdings
2.1%
Bicycle Therapeutics plc (BCYC)
Young Alethia — Chief Financial Officer
Shares
2,456
Price
$6.45
Total Value
$15.84K
Shares Held After
88,959
% of Holdings
2.7%
Bicycle Therapeutics plc (BCYC)
Milnes Alistair — CHIEF OPERATING OFFICER
Shares
3,416
Price
$6.46
Total Value
$22.07K
Shares Held After
136,717
% of Holdings
2.4%
Bicycle Therapeutics plc (BCYC)
Hannay Michael Charles Ferguson — CHIEF PROD & SUPPLY CHAIN OFF
Shares
2,367
Price
$6.45
Total Value
$15.27K
Shares Held After
97,908
% of Holdings
2.4%
Bicycle Therapeutics plc (BCYC)
Skynner Michael — CHIEF TECHNOLOGY OFFICER
Shares
3,266
Price
$6.46
Total Value
$21.10K
Shares Held After
161,966
% of Holdings
2.0%
Bicycle Therapeutics plc (BCYC)
Thompson Travis Alvin — CHIEF ACCOUNTING OFFICER
Shares
1,115
Price
$6.45
Total Value
$7.19K
Shares Held After
66,265
% of Holdings
1.7%
Surrozen, Inc./DE (SRZN)
Williams Charles O — Chief Operating Officer
Shares
1,566
Price
$19.87
Total Value
$31.11K
Shares Held After
12,982
% of Holdings
10.8%
Surrozen, Inc./DE (SRZN)
Li Yang — Exec. Vice President, Research
Shares
1,118
Price
$19.87
Total Value
$22.21K
Shares Held After
16,091
% of Holdings
6.5%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
71,339
Price
$38.10
Total Value
$2.72M
Shares Held After
138,976
% of Holdings
33.9%
ANAPTYSBIO, INC (ANAB)
LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Shares
2,983
Price
$43.26
Total Value
$129.04K
Shares Held After
13,251
% of Holdings
18.4%
ANAPTYSBIO, INC (ANAB)
Lizzul Paul F. — Chief Medical Officer
Shares
4,219
Price
$43.26
Total Value
$182.51K
Shares Held After
33,303
% of Holdings
11.2%
ANAPTYSBIO, INC (ANAB)
MULROY DENNIS — CHIEF FINANCIAL OFFICER
Shares
3,363
Price
$43.26
Total Value
$145.48K
Shares Held After
14,330
% of Holdings
19.0%
ANAPTYSBIO, INC (ANAB)
Faga Daniel — Director
Shares
15,309
Price
$43.26
Total Value
$662.27K
Shares Held After
458,139
% of Holdings
3.2%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
42,544
Price
$17.10
Total Value
$727.32K
Shares Held After
0
% of Holdings
100.0%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
100
Price
$23.20
Total Value
$2.32K
Shares Held After
922,240
% of Holdings
0.0%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
2,053
Price
$22.34
Total Value
$45.86K
Shares Held After
922,340
% of Holdings
0.2%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Milanova Tsveta — Chief Commercial Officer
Shares
2,872
Price
$27.02
Total Value
$77.60K
Shares Held After
34,793
% of Holdings
7.6%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
429
Price
$494.27
Total Value
$212.04K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
201
Price
$493.47
Total Value
$99.19K
Shares Held After
429
% of Holdings
31.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
598
Price
$492.44
Total Value
$294.48K
Shares Held After
630
% of Holdings
48.7%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
647
Price
$491.35
Total Value
$317.90K
Shares Held After
1,228
% of Holdings
34.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
893
Price
$490.11
Total Value
$437.67K
Shares Held After
1,875
% of Holdings
32.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
364
Price
$489.49
Total Value
$178.17K
Shares Held After
2,768
% of Holdings
11.6%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
641
Price
$488.38
Total Value
$313.05K
Shares Held After
3,132
% of Holdings
17.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
461
Price
$487.40
Total Value
$224.69K
Shares Held After
3,773
% of Holdings
10.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
899
Price
$486.05
Total Value
$436.96K
Shares Held After
4,234
% of Holdings
17.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
629
Price
$484.99
Total Value
$305.06K
Shares Held After
5,133
% of Holdings
10.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
375
Price
$483.80
Total Value
$181.43K
Shares Held After
5,762
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
471
Price
$482.72
Total Value
$227.36K
Shares Held After
6,137
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
891
Price
$481.86
Total Value
$429.34K
Shares Held After
6,608
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
376
Price
$480.68
Total Value
$180.74K
Shares Held After
7,499
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
797
Price
$494.27
Total Value
$393.94K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
374
Price
$493.47
Total Value
$184.56K
Shares Held After
797
% of Holdings
31.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,110
Price
$492.44
Total Value
$546.61K
Shares Held After
1,171
% of Holdings
48.7%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,201
Price
$491.35
Total Value
$590.11K
Shares Held After
2,281
% of Holdings
34.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,659
Price
$490.11
Total Value
$813.09K
Shares Held After
3,482
% of Holdings
32.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
677
Price
$489.49
Total Value
$331.38K
Shares Held After
5,141
% of Holdings
11.6%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,189
Price
$488.38
Total Value
$580.68K
Shares Held After
5,818
% of Holdings
17.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
856
Price
$487.40
Total Value
$417.22K
Shares Held After
7,007
% of Holdings
10.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,669
Price
$486.05
Total Value
$811.22K
Shares Held After
7,863
% of Holdings
17.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,169
Price
$485.00
Total Value
$566.96K
Shares Held After
9,532
% of Holdings
10.9%
Showing 3001–3050 of 3481 transactions (page 61 of 70)